Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-382457

CORCEPT THERAPEUTICS INC · CORT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Gary Charles Robb
Officer — Chief Business Officer
Period of report
Sep 1, 2026
Accepted (ET)
Sep 3, 2026 · 9:03 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001088856

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Sep 1, 2026A164$113.38A13,590D
Common StockF4,F3Sep 1, 2026A164$0.00A13,754D
Common StockF6,F7Sep 2, 2026F91$113.38D13,663D
Common StockF8holding———39,716IGary Charles Robb TTE Robb Revocable Trust
Common StockF9holding———15,571ICustodial Account for Child
Common StockF10holding———15,571ICustodial Account for Child

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

The power of attorney under which this form was signed is on file with the Commission.